| [1] |
LI Xu, HE Xiaoyu, ZHAO Pinghua, SHANG Xiaoyan.
Uncertainty Evaluation and Z-Value Analysis for Determination of the Content of Stilbene Glucoside in Proficiency Testing Samples of Polygonum multiflorum by HPLC
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(1): 18-18-23.
|
| [2] |
DAI Qi, GUI Ziya, DONG Zhaowei, YE Qiaobo, LUO Xiao, ZHANG Liang.
Research Progress on the Active Constituents of Cratargi Fructus and Their Mechanism of Action in Treating Nonalcoholic Fatty Liver Disease
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(1): 39-39-45.
|
| [3] |
CHENG Qianqian, ZHANG Yali.
Investigation on Medication Adherence in Elderly Patients with Multiple Chronic Diseases and Its Related Factors
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(1): 77-77-80.
|
| [4] |
YAN Ruoxi.
Analysis of Quality Management System Elements in Pharmaceutical Inspectorates from Total Quality Management Perspective
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(1): 1-1-8.
|
| [5] |
LIU Shuxia, ZHOU Yongkang.
Research and Development Progress of Fresh Chinese Medicine
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(1): 46-46-49.
|
| [6] |
ZHAO Chenxi, XIE Ying, YANG Liu, YANG Yabin, LI Tingting.
Investigating the Mechanism of Action of Sambucus adnata Wall. in the Treatment of Bone Fracture Based on Network Pharmacology and Molecular Docking Technology
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(1): 32-32-38.
|
| [7] |
JIA Dengying, ZHANG Jie, LI Pei, PANG Bo, FANG Xia, WANG Hongmei, ZHAO Wenfa.
Advances in the Application of ICP-MS in Pharmaceutical Quality Control
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(1): 14-14-17.
|
| [8] |
HU Bin, DONG Liang.
Effects of Anlotinib Combined with TP Chemotherapy Regimen on Inflammatory Response and Tumor Markers in Patients with Advanced Non-Small Cell Lung Cancer
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(1): 56-56-61.
|
| [9] |
HUAN Jing, NI Qi.
Exploration and Reflection on the Training of Clinical Research Coordinators
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(1): 74-74-76.
|
| [10] |
MA Zhengran, HUANG Ziyi, WANG Xiaoying, YANG Wenlong, ZHU Zhiwei.
A Knowledge Graph-Based Study on the Medication Rules of Dali Ethnic Folk Empirical Prescriptions for Bi Syndrome
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(1): 24-24-31.
|
| [11] |
WANG Fang, CHEN Lin, LI Huyu, WANG Shengchun.
Clinical Study of Tacrolimus Combined with Five Vitamins and Lysine Granules in the Treatment of Pediatric Vitiligo
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(1): 68-68-73.
|
| [12] |
LI Yong, QI Yujie, YANG Dongwei.
Comparative Efficacy of Sacubitril/Valsartan Sodium versus Perindopril in Elderly Patients with HFrEF and Hypertension
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(1): 62-62-67.
|
| [13] |
WEN Qinghui, GUO Shujin.
Research Progress on the Chemical Composition, Pharmacological Effects and Toxicology of Acorus tatarinowii Schott
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026, 43(1): 50-50-55.
|
| [14] |
ZHANG Hanwen, HAN Ning, ZHAO Wei.
Clinical Observation of Labetalol Combined with Nifedipine in the Treatment of Gestational Hypertension
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2025, 42(6): 464-464-468.
|
| [15] |
FENG Junyi, LI Ye, ZHANG Bingchang, SHI Hui, YANG Jue.
Analysis of the Clinical Trial Research for Diabetes Drugs Based on the China Drug Trials Platform
[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2025, 42(6): 492-492-496.
|